
Articles
-
Sep 4, 2024 |
healio.com | Shawn Carter |Gina Brockenbrough |Anna Burgner |Alissa A. Ice
Anna Burgner, MD, MEHP, and Alissa A. Ice, MD Preeclampsia is the most common glomerular disease in the world, yet there remains a paucity of data regarding the long-term sequelae, particularly amongst patients with chronic kidney disease. Generally, patients with preeclampsia, which is characterized by endothelial dysfunction, are at increased risk for cardiovascular complications, diabetes and CKD, but the implications to CKD progression have been poorly defined.
-
Aug 13, 2024 |
healio.com | Shawn Carter |Gina Brockenbrough |Anna Burgner |Alissa A. Ice
Anna Burgner, MD, MEHP, and Alissa A. Ice, MD Preeclampsia is the most common glomerular disease in the world, yet there remains a paucity of data regarding the long-term sequelae, particularly amongst patients with chronic kidney disease. Generally, patients with preeclampsia, which is characterized by endothelial dysfunction, are at increased risk for cardiovascular complications, diabetes and CKD, but the implications to CKD progression have been poorly defined.
-
Sep 27, 2023 |
data.asn-online.org | Kurtis Pivert |Anna Burgner |Raad Chowdhury |Jason Cobb
This year’s survey saw the greatest percentage of fellow participants recommending nephrology—92%—including 96% of USMGs and 89% of IMGs (Figure 6).
-
Sep 11, 2023 |
healio.com | Anna Burgner |Gina Brockenbrough
You've successfully added Nephrology: Chronic Kidney Disease to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. It is critical for nephrologists to provide counseling and treatment when women’s health issues intersect with kidney disease. Much work remains.
-
Jul 6, 2023 |
kidneynews.org | Anna Burgner
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →